🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06738654
Recruiting Not applicable

Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.

NCT06738654 · tracked via the Priya Life Science China tracker
Sponsor
Xu Yan
Phase
Not applicable
Started
2024-12-31
Last updated
2026-08-21

Condition(s) studied

Invasive Breast Carcinoma

Investigational drug(s) / intervention(s)

robot-surgerytraditional open surgry

robot-surgery: Breast-conserving surgery for breast cancer using single-port robotic surgery.

traditional open surgry: Breast-conserving surgery for breast cancer using traditional open surgery.

Study summary

Evaluate the safety,feasibility and quality of life(QoL)of single-port robotic surgery in breast-conserving surgery, compare and analyze the advantages and disadvantages of single-port robotic surgery and open surgery in terms of complications, postoperative complications, perioperative recovery effects, and safety in breast cancer breast-conserving surgery, in order to select a more effective and safe surgical method. Subjects who meet the inclusion criteria will enter the research process, with surgery including SPr-breast-conserving surgery or open-breast-conserving surgery, and the choice of the two surgical methods is based on the patient's financial situation and the availability of equipment;

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. The patient himself has very high requirements for beauty, and requires no scar on the chest; 2. No chest surgery and radiotherapy. 3. No contraindications to surgery and anesthesia. 4. Clinical I, stage of early breast cancer and the breast has an appropriate volume, can maintain a good breast shape after surgery. 5. Patients in the clinical period who meet the standard of breast conservation surgery after preoperative treatment. 6. Age: ≥18 years old. Exclusion Criteria: 1. Inflammatory breast cancer. 2. The tumor is extensive and it's difficult to achieve negative margins or an ideal breast - conserving appearance. 3. Diffusely distributed malignant - characteristic calcifications. 4. The margin is positive after local extensive tumor resection, and a negative margin in pathological examination still can't be ensured after re - resection. 5. The patient refuses.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Aramy medical center. Chongqing Chongqing Municipality Not Yet Recruiting
Army Medical Center Chongqing Chongqing Municipality Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06738654 on ClinicalTrials.gov ↗ ← All trials in China